EUVIMEDEUVIMED entdecken
Open Access

Pain Mechanisms Associated With Disease Activity in Patients With Rheumatoid Arthritis Treated With Disease-Modifying Antirheumatic Drugs: A Regression Tree Analysis

Alyssa Wohlfahrt iD, Lutfiyya N Muhammad iD, Jing Song iD, Dorothy D Dunlop iD, Tuhina Neogi iD, Clifton O Bingham iD, Marcy B Bolster iD, Wendy Marder iD, Daniel J Clauw iD, Yvonne C Lee iD

The Journal of Rheumatology · 2023-06 · 50 (6) · 741-747

DOI: 10.3899/jrheum.220500 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Rheumatology, online erschienen am 15.01.2023. Verfasst von Alyssa Wohlfahrt und 9 weiteren Autor:innen. Beteiligte Einrichtung: A. Wohlfahrt, MS, Tufts University School of Medicine, Boston, Massachusetts. Hauptthemen laut MEDLINE: Antirheumatic Agents, Arthritis, Rheumatoid. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Although pain affects the assessment of disease activity in patients with rheumatoid arthritis (RA), pain is not always directly related to peripheral joint inflammation. Peripheral and central nervous system regulatory mechanisms also affect pain perception. We used regression tree methodology to identify mechanisms most predictive of disease activity after disease-modifying antirheumatic drug (DMARD) treatment.

Methods

Disease activity was evaluated using the Disease Activity Score in 28 joints (DAS28) in 176 patients with RA, before and after starting a DMARD. Quantitative sensory testing (QST), including pressure pain thresholds (PPTs), temporal summation, and conditioned pain modulation (CPM), were used to assess pain mechanisms. Regression tree methodology was used to determine the QST modalities most predictive of DAS28 after DMARD treatment.

Results

This analysis identified 4 groups defined by baseline DAS28 category and either knee PPT (a combined measure of peripheral and central nervous system dysregulation) or CPM (a measure of descending pain inhibition). Among patients starting with low/moderate disease activity, lower knee PPT (PPT ≤ 4.65 kgf) most strongly predicted higher posttreatment disease activity (group 1 mean DAS28 2.8 [SD 1.0] vs group 2 mean DAS28 3.5 [SD 1.0]). Among patients starting with high baseline disease activity, less efficient descending pain modulation (CPM ≤ 1.55) most strongly predicted higher posttreatment disease activity (group 3 mean DAS28 3.4 [SD 1.4] vs group 4 mean DAS28 4.6 [SD 1.1]).

Conclusion

These results highlight the importance of identifying and treating aberrant peripheral and central pain regulation in patients with RA starting or switching DMARD therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antirheumatic AgentsArthritis, RheumatoidHumansPainSeverity of Illness IndexTreatment Outcome

Stichwörter der Autor:innen

disease-modifying antirheumatic drugsinflammationpain managementpain perceptionpain thresholdsrheumatoid arthritis

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • A. Wohlfahrt, MS, Tufts University School of Medicine, Boston, Massachusetts.
  • L.N. Muhammad, PhD, MPH, J. Song, MS, D.D. Dunlop, PhD, Y.C. Lee, MD, MMSc, Northwestern University, Chicago, Illinois.
  • T. Neogi, MD, PhD, Boston University School of Medicine, Boston, Massachusetts.
  • C.O. Bingham III, MD, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • M.B. Bolster, MD, Massachusetts General Hospital, Boston, Massachusetts.
  • W. Marder, MD, MS, D.J. Clauw, MD, University of Michigan, Ann Arbor, Michigan, USA.

ORCID-Profile: Alyssa Wohlfahrt, Lutfiyya N Muhammad, Jing Song, Dorothy D Dunlop, Tuhina Neogi, Clifton O Bingham, Marcy B Bolster, Wendy Marder, Daniel J Clauw, Yvonne C Lee

Förderung

  • NIAMS NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Wohlfahrt, A., Muhammad, L. N., Song, J., Dunlop, D. D., Neogi, T., Bingham, C. O., Bolster, M. B., Marder, W., Clauw, D. J., & Lee, Y. C. (2023). Pain Mechanisms Associated With Disease Activity in Patients With Rheumatoid Arthritis Treated With Disease-Modifying Antirheumatic Drugs: A Regression Tree Analysis. The Journal of Rheumatology, 50(6), 741-747. https://doi.org/10.3899/jrheum.220500

Vancouver

Wohlfahrt A, Muhammad LN, Song J, Dunlop DD, Neogi T, Bingham CO, et al. Pain Mechanisms Associated With Disease Activity in Patients With Rheumatoid Arthritis Treated With Disease-Modifying Antirheumatic Drugs: A Regression Tree Analysis. The Journal of Rheumatology. 2023;50(6):741-747. doi:10.3899/jrheum.220500

BibTeX
@article{Wohlfahrt2023,
  author = {Wohlfahrt, Alyssa and Muhammad, Lutfiyya N and Song, Jing and Dunlop, Dorothy D and Neogi, Tuhina and Bingham, Clifton O and Bolster, Marcy B and Marder, Wendy and Clauw, Daniel J and Lee, Yvonne C},
  title = {Pain Mechanisms Associated With Disease Activity in Patients With Rheumatoid Arthritis Treated With Disease-Modifying Antirheumatic Drugs: A Regression Tree Analysis},
  journal = {The Journal of Rheumatology},
  year = {2023},
  volume = {50},
  number = {6},
  pages = {741--747},
  doi = {10.3899/jrheum.220500}
}
Kostenlos starten →